-
Real-World Treatment Patterns Among Patients Newly Diagnosed With Chronic Inflammatory Demyelinating Polyneuropathy in the United States
Sep 9, 2025, 16:22 PM -
Treatment Patterns in Epithelial Ovarian Cancer (EOC) With a Focus on Recurrent EOC and PARPi Progressors: A Targeted Literature Review Across Selected Countries
Sep 9, 2025, 16:22 PM -
Development of a Partitioned Survival Model Template for Oncology Indications: A Flexible and Customizable Framework
Sep 9, 2025, 16:22 PM -
What Drives European Union (EU) Health Technology Assessment (HTA) Decisions in Melanoma? A Targeted Review on Clinical Evidence Critiques
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Adding Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors or Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists to Standard Therapy in Thai Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Sep 9, 2025, 16:22 PM -
Characteristics and Treatment of Prevalent Heart Failure in the US: A Cross-Sectional Analysis of Annual Trends From 2014-2023
Sep 9, 2025, 16:22 PM -
Bimekizumab Demonstrated Sustained Long-Term Improvements in Health-Related Quality of Life and Work Productivity in Patients With Active Psoriatic Arthritis: 3-Year Results from Two Phase 3 Studies
Sep 9, 2025, 16:22 PM -
When Less Is More? Learnings From a Recent NICE Submission Utilizing a Novel Predictive Individual-Level Surrogacy Approach to Predict Overall Survival (OS) in the Absence of Trial-Level Evidence
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization Associated With Acute Pancreatitis in Patients With Familial Chylomicronemia Syndrome Treated With Olezarsen: A Post Hoc Analysis of Balance Study Data
Sep 9, 2025, 16:22 PM -
Malnutrition-Related Healthcare Costs in Hospitalized IBD Patients: A Nationwide Real-World Data Analysis in Italy
Sep 9, 2025, 16:22 PM -
Estimating the Mean Time in Treatment-Free Remission for Patients in Early Line CML
Sep 9, 2025, 16:22 PM -
Health Economic Assessment of Cefepime-Enmetazobactam for Treating Complicated Urinary Tract Infections: A German Payer Perspective
Sep 9, 2025, 16:22 PM -
Mapping to EQ-5D Utility in Knee Osteoarthritis: A Comparative Evaluation of WOMAC and SF-36 Algorithms in the STEP 9 Trial
Sep 9, 2025, 16:22 PM -
High-Fidelity Synthetic Patient Pathway Generation and Validation for NSCLC Using A Tabular Variational Autoencoder (TVAE)
Sep 9, 2025, 16:22 PM -
Evaluation of the Use of ChatGPT in Data Extraction for Systematic Literature Reviews: Friend, Foe, or Fiction?
Sep 9, 2025, 16:22 PM -
Societal and Economic Impact of Long-Acting Injectable Buprenorphine (LAIB) Compared With Standard Opioid Substitution Therapy (OST) in France
Sep 9, 2025, 16:22 PM -
Evaluation of the Measurement Properties of the German LupusPRO™ for Swiss-German SLE Patients
Sep 9, 2025, 16:22 PM -
Evaluation of the Societal Impact of Emicizumab in France Since Its Market Authorization: Budget Impact From 2018 to 2024
Sep 9, 2025, 16:22 PM -
Transplant Eligibility in DLBCL: A Real-World Analysis of German Hospital Billing Data
Sep 9, 2025, 16:22 PM -
Can Estimands Support Aligned Evidence Generation for EU HTA? Reflections on Their Role in Joint Clinical Assessments, PICO Alignment, and Beyond
Sep 9, 2025, 16:22 PM
